ROR1 and colonic neoplasm: Studies have shown that ATL-2 can inhibit the viability and proliferation of colon cancer cells by regulating the expression of various genes in the XIST/miR-30a-5p/ROR1 pathway and, at the same time, enhance the chemosensitivity of colon cancer cells and increase the antitumor efficacy of chemotherapeutic agents.